Jamie S. Chua

Jamie S. Chua

Auto-generated profile, based on publicly available information

Jamie S. Chua

Leiden University Medical Center

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
JCJamie S. Chua
Jamie S. Chua
HBHans Baelde
Hans Baelde
MZMalu Zandbergen
Malu Zandbergen
SWSuzanne Wilhelmus
Suzanne Wilhelmus
LELeendert A. van Es
Leendert A. van Es
DCDanielle Cohen
Danielle Cohen
Complement activation has a major role in thrombotic microangiopathy (TMA), a disorder that can occur in a variety of clinical conditions. Promising results of recent trials with terminal complement-inhibiting drugs call for biomarkers identifying patients who might benefit from this treatment. The primary aim of this study was to determine the prevalence and localization of complement factor C4d in kidneys of patients with TMA. The secondary aims were to determine which complement pathways lead to C4d deposition and to determine whether complement activation results in deposition of the terminal complement complex. We examined 42 renal sections with histologically confirmed TMA obtained from a heterogeneous patient group. Deposits of C4d, mannose-binding lectin, C1q, IgM, and C5b-9 were scored in the glomeruli, peritubular capillaries, and arterioles. Notably, C4d deposits were present in 88.1% of TMA cases, and the various clinical conditions had distinct staining patterns within the various compartments of the renal vasculature. Classical pathway activation was observed in 90.5% of TMA cases. C5b-9 deposits were present in 78.6% of TMA cases and in 39.6% of controls (n=53), but the staining pattern differed between cases and controls. In conclusion, C4d is a common finding in TMA, regardless of the underlying clinical condition. Moreover, C5b-9 was present in >75% of the TMA samples, suggesting that terminal complement inhibitors may have a beneficial effect in these patients. C4d and C5b-9 should be investigated as possible diagnostic biomarkers in the clinical work-up of patients suspected of having complement-mediated TMA.

1 August 2019 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
JCJamie S. Chua
Jamie S. Chua
MZMalu Zandbergen
Malu Zandbergen
RWRon Wolterbeek
Ron Wolterbeek
HBHans J. Baelde
Hans J. Baelde
LELeendert A. van Es
Leendert A. van Es
IBIngeborg M. Bajema
Ingeborg M. Bajema

1 July 2015 in Hypertension
Verified
Journal Article
Closed access
PDF file
MPMarlies Penning
Marlies Penning
JCJamie S. Chua
Jamie S. Chua
CKCees van Kooten
Cees van Kooten
MZMalu Zandbergen
Malu Zandbergen
ABAletta Buurma
Aletta Buurma
HBHans Baelde
Hans Baelde
A growing body of evidence suggests that complement dysregulation plays a role in the pathogenesis of preeclampsia. The kidney is one of the major organs affected in preeclampsia. Because the kidney is highly susceptible to complement activation, we hypothesized that preeclampsia is associated with renal complement activation. We performed a nationwide search for renal autopsy material in the Netherlands using a computerized database (PALGA). Renal tissue was obtained from 11 women with preeclampsia, 25 pregnant controls, and 14 nonpregnant controls with hypertension. The samples were immunostained for C4d, C1q, mannose-binding lectin, properdin, C3d, C5b-9, IgA, IgG, and IgM. Preeclampsia was significantly associated with renal C4d—a stable marker of complement activation—and the classical pathway marker C1q. In addition, the prevalence of IgM was significantly higher in the kidneys of the preeclamptic women. No other complement markers studied differed between the groups. Our findings in human samples were validated using a soluble fms-like tyrosine kinase 1 mouse model of preeclampsia. The kidneys in the soluble fms-like tyrosine kinase 1−injected mice had significantly more C4 deposits than the control mice. The association between preeclampsia and renal C4d, C1q, and IgM levels suggests that the classical complement pathway is involved in the renal injury in preeclampsia. Moreover, our finding that soluble fms-like tyrosine kinase 1−injected mice develop excess C4 deposits indicates that angiogenic dysregulation may play a role in complement activation within the kidney. We suggest that inhibiting complement activation may be beneficial for preventing the renal manifestations of preeclampsia.

12 November 2021 in Endoscopy International Open
Verified
Journal Article
Open access
PDF file
JCJamie S. Chua
Jamie S. Chua
HDHao Dang
Hao Dang
LZLiselotte W. Zwager
Liselotte W. Zwager
Nik DekkersNik Dekkers
Nik Dekkers
JHJames C. H. Hardwick
James C. H. Hardwick
OGon behalf of the Dutch eFTR Working Group
on behalf of the Dutch eFTR Working Group
Endoscopic treatment of large laterally spreading tumors (LSTs) with a focus of submucosally invasive colorectal cancer (T1 CRC) can be challenging. We evaluated outcomes of a hybrid resection technique using piecemeal endoscopic mucosal resection (pEMR) and endoscopic full-thickness resection (eFTR) in patients with large colonic LSTs containing suspected T1 CRC. Six hybrid pEMR-eFTR procedures for T1 CRCs were registered in a nationwide eFTR registry between July 2015 and December 2019. In all cases, the invasive part of the lesion was successfully isolated with eFTR; with eFTR, histologically complete resection of the invasive part was achieved in 5 /6 patients (83.3 %). No adverse events occurred during or after the procedure. The median follow-up time was 10 months (range 6–27), with all patients having undergone ≥ 1 surveillance colonoscopy. One patient had a small adenomatous recurrence, which was removed endoscopically. In conclusion, hybrid pEMR-eFTR is a promising noninvasive treatment modality that seems feasible for a selected group of patients with large LSTs containing a small focus of T1 CRC.

22 April 2024 in Canadian Medical Education Journal
Verified
Journal Article
Open access
PDF file
JCJamie S Chua
Jamie S Chua
MDMerel Van Diepen
Merel Van Diepen
MTMarjolijn D Trietsch
Marjolijn D Trietsch
FDFriedo W Dekker
Friedo W Dekker
JSJohanna Schönrock-Adema
Johanna Schönrock-Adema
JBJacqueline Bustraan
Jacqueline Bustraan
Background: Although medical courses are frequently evaluated via surveys with Likert scales ranging from “strongly agree” to “strongly disagree,” low response rates limit their utility. In undergraduate medical education, a new method with students predicting what their peers would say, required fewer respondents to obtain similar results. However, this prediction-based method lacks validation for continuing medical education (CME), which typically targets a more heterogeneous group than medical students. Methods: In this study, 597 participants of a large CME course were randomly assigned to either express personal opinions on a five-point Likert scale (opinion-based method; n = 300) or to predict the percentage of their peers choosing each Likert scale option (prediction-based method; n = 297). For each question, we calculated the minimum numbers of respondents needed for stable average results using an iterative algorithm. We compared mean scores and the distribution of scores between both methods. Results: The overall response rate was 47%. The prediction-based method required fewer respondents than the opinion-based method for similar average responses. Mean response scores were similar in both groups for most questions, but prediction-based outcomes resulted in fewer extreme responses (strongly agree/disagree). Conclusions: We validated the prediction-based method in evaluating CME. We also provide practical considerations for applying this method.